NCT02078609
- Conditions
- AML and High Risk MDS, Bone Marrow Diseases, Hematologic Diseases, +7 more
- Locations
-
- Novartis Investigative Site Ann Arbor, Michigan, United States
- Novartis Investigative Site Prahran, Victoria, Australia
- Novartis Investigative Site Marseille, France
- Novartis Investigative Site Ulm, Germany